AU2001245988A1 - Microspheres for active embolization - Google Patents
Microspheres for active embolizationInfo
- Publication number
- AU2001245988A1 AU2001245988A1 AU2001245988A AU4598801A AU2001245988A1 AU 2001245988 A1 AU2001245988 A1 AU 2001245988A1 AU 2001245988 A AU2001245988 A AU 2001245988A AU 4598801 A AU4598801 A AU 4598801A AU 2001245988 A1 AU2001245988 A1 AU 2001245988A1
- Authority
- AU
- Australia
- Prior art keywords
- embolization
- microspheres
- angiogenic
- present
- injectable compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000010102 embolization Effects 0.000 title abstract 3
- 239000004005 microsphere Substances 0.000 title 1
- 230000002491 angiogenic effect Effects 0.000 abstract 2
- 239000007972 injectable composition Substances 0.000 abstract 2
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000002651 drug therapy Methods 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19189900P | 2000-03-24 | 2000-03-24 | |
US60191899 | 2000-03-24 | ||
PCT/US2001/009619 WO2001072281A2 (fr) | 2000-03-24 | 2001-03-23 | Microspheres permettant une embolisation active |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001245988A1 true AU2001245988A1 (en) | 2001-10-08 |
Family
ID=22707362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001245988A Abandoned AU2001245988A1 (en) | 2000-03-24 | 2001-03-23 | Microspheres for active embolization |
Country Status (10)
Country | Link |
---|---|
US (4) | US8697137B2 (fr) |
EP (3) | EP1820495B1 (fr) |
JP (4) | JP2003528130A (fr) |
KR (2) | KR100872884B1 (fr) |
CN (2) | CN1430505A (fr) |
AT (1) | ATE374597T1 (fr) |
AU (1) | AU2001245988A1 (fr) |
DE (2) | DE60130743T2 (fr) |
ES (2) | ES2551164T3 (fr) |
WO (1) | WO2001072281A2 (fr) |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6660301B1 (en) | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
FR2784580B1 (fr) | 1998-10-16 | 2004-06-25 | Biosepra Inc | Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci |
US6676971B2 (en) | 2000-03-13 | 2004-01-13 | Biocure, Inc. | Embolic compositions |
JP5460939B2 (ja) | 2000-03-13 | 2014-04-02 | バイオコンパティブルズ ユーケー リミテッド | ヒドロゲル生物医学用製品 |
US6436424B1 (en) | 2000-03-20 | 2002-08-20 | Biosphere Medical, Inc. | Injectable and swellable microspheres for dermal augmentation |
EP1274472A2 (fr) | 2000-03-20 | 2003-01-15 | Biosphere Medical, Inc. | Microspheres injectables, susceptibles de foisonnement, visant a faire gonfler un tissu |
US7338657B2 (en) * | 2001-03-15 | 2008-03-04 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
CN1430505A (zh) | 2000-03-24 | 2003-07-16 | 生物领域医疗公司 | 用于主动栓塞术的微球体 |
US20040266983A1 (en) * | 2000-08-17 | 2004-12-30 | Reeve Lorraine E | Purified polyoxyalkylene block copolymers |
US9080146B2 (en) | 2001-01-11 | 2015-07-14 | Celonova Biosciences, Inc. | Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface |
US20030236457A1 (en) * | 2002-04-24 | 2003-12-25 | Mericle Robert A. | Method of endovascular brain mapping |
US7332160B2 (en) | 2002-07-12 | 2008-02-19 | Boston Scientific Scimed, Inc. | Medical device and method for tissue removal and repair |
US7588825B2 (en) * | 2002-10-23 | 2009-09-15 | Boston Scientific Scimed, Inc. | Embolic compositions |
AU2004224439B2 (en) * | 2003-03-24 | 2010-07-15 | Genzyme Corporation | Temporary embolization using inverse thermosensitive polymers |
JP5186109B2 (ja) | 2003-09-25 | 2013-04-17 | ラトガース,ザ ステート ユニバーシティ | 塞栓治療のための本質的に放射線不透過性であるポリマー生産物 |
US7901770B2 (en) | 2003-11-04 | 2011-03-08 | Boston Scientific Scimed, Inc. | Embolic compositions |
WO2005046438A2 (fr) * | 2003-11-06 | 2005-05-26 | Pluromed, Inc. | Pince interne pour procedures chirurgicales |
WO2005087193A2 (fr) * | 2004-03-11 | 2005-09-22 | Biocompatibles Uk Limited | Chimioembolisation |
US8080577B2 (en) * | 2004-05-06 | 2011-12-20 | Bioresponse, L.L.C. | Diindolylmethane formulations for the treatment of leiomyomas |
US8821859B2 (en) * | 2004-05-19 | 2014-09-02 | Agency For Science, Technology And Research | Methods and articles for the delivery of therapeutic agents |
EP1600456A1 (fr) * | 2004-05-28 | 2005-11-30 | Deutsches Krebsforschungszentrum | Procédé de purification des polymères portant une groupe lipophiles. |
WO2006013309A1 (fr) * | 2004-08-03 | 2006-02-09 | Biocompatibles Uk Limited | Rélargage de médicaments à partir des agents emboliques |
WO2006013376A2 (fr) * | 2004-08-04 | 2006-02-09 | Biocompatibles Uk Limited | Liberation de medicaments a partir d'agents emboliques |
EP1804773B1 (fr) | 2004-10-25 | 2011-03-30 | CeloNova BioSciences Germany GmbH | Particules polymeres chargeables pour des applications therapeutiques et/ou diagnostiques et methode de preparation et d'utilisation de ces particules |
US11426355B2 (en) | 2004-10-25 | 2022-08-30 | Varian Medical Systems, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
US9114162B2 (en) | 2004-10-25 | 2015-08-25 | Celonova Biosciences, Inc. | Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same |
US9107850B2 (en) | 2004-10-25 | 2015-08-18 | Celonova Biosciences, Inc. | Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same |
US20210299056A9 (en) | 2004-10-25 | 2021-09-30 | Varian Medical Systems, Inc. | Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods |
DE602005026328D1 (de) * | 2004-12-30 | 2011-03-24 | Bioresponse Llc | Verwendung von diindolylmethan-verwandten indolen zur behandlung und prävention von erkrankungen im zusammenhang mit dem respiratory syncytial virus |
US7963287B2 (en) | 2005-04-28 | 2011-06-21 | Boston Scientific Scimed, Inc. | Tissue-treatment methods |
WO2006119968A2 (fr) | 2005-05-09 | 2006-11-16 | Biosphere Medical S.A. | Compositions et procedes d'utilisation de microspheres et agents de contraste non ioniques |
US9463426B2 (en) | 2005-06-24 | 2016-10-11 | Boston Scientific Scimed, Inc. | Methods and systems for coating particles |
FR2892927B1 (fr) * | 2005-11-04 | 2008-01-11 | Oreal | Utilisation d'une composition cosmetique comprenant des particules spheriques flexibles pour la mise en forme des cheveux |
EP1978938B1 (fr) * | 2006-01-24 | 2015-09-09 | Biocompatibles UK Limited | Procédé de chargement de médicament dans des particules polymères |
US20080039890A1 (en) * | 2006-01-30 | 2008-02-14 | Surgica Corporation | Porous intravascular embolization particles and related methods |
EP1986707A2 (fr) * | 2006-01-30 | 2008-11-05 | Surgica Corporation | Particules d'embolisation intravasculaire compressible, procedes connexes et systemes d'administration |
US8062673B2 (en) | 2006-04-11 | 2011-11-22 | E I Du Pont De Nemours And Company | Process for embolization using swellable and deformable microspheres |
US8252339B2 (en) | 2006-04-11 | 2012-08-28 | Massachusetts Institute Of Technology | Medical treatment applications of swellable and deformable microspheres |
US7838035B2 (en) | 2006-04-11 | 2010-11-23 | E. I. Du Pont De Nemours And Company | Microsphere powder of high density, swellable, deformable, durable occlusion-forming microspheres |
US7794755B2 (en) * | 2006-04-11 | 2010-09-14 | E.I. Du Pont De Nemours And Company | Process for preparation of swellable and deformable microspheres |
CN100518719C (zh) * | 2006-07-05 | 2009-07-29 | 中国科学院大连化学物理研究所 | 一种复合基质的多功能动脉栓塞剂的制备方法 |
BRPI0717753B1 (pt) | 2006-10-27 | 2022-04-12 | Bioresponse, Llc | Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição |
US20080181952A1 (en) * | 2006-12-11 | 2008-07-31 | Pluromed, Inc. | Perfusive Organ Hemostasis |
KR20090114469A (ko) * | 2007-02-22 | 2009-11-03 | 플루로메드, 인코포레이티드 | 수술후 생물학적 유체 흐름을 제어하기 위한 역 감열 폴리머의 용도 |
US9987221B2 (en) * | 2007-08-23 | 2018-06-05 | Boston Scientific Scimed, Inc. | Injectable hydrogel compositions |
US20110104052A1 (en) * | 2007-12-03 | 2011-05-05 | The Johns Hopkins University | Methods of synthesis and use of chemospheres |
EP2123256A1 (fr) | 2008-05-19 | 2009-11-25 | Ruhr-Universität Bochum | Nanoémulsions de perfluocarbone avec surface améliorée à endocytose pour un transfert de gènes |
WO2010062678A2 (fr) * | 2008-10-30 | 2010-06-03 | David Liu | Échafaudages biocompatibles poreux microsphériques, et procédés et appareil pour la fabrication de ces échafaudages |
CA2754200A1 (fr) * | 2009-03-02 | 2010-09-10 | Assistance Publique - Hopitaux De Paris | Biomateriau injectable |
US8877158B2 (en) | 2009-06-12 | 2014-11-04 | Fujifilm Corporation | Targeting agent to newly formed blood vessels |
WO2011044236A1 (fr) | 2009-10-06 | 2011-04-14 | Regents Of The University Of Minnesota | Microsphères d'embolisation biorésorbables |
US9089512B2 (en) * | 2009-12-18 | 2015-07-28 | President And Fellows Of Harvard College | Active scaffolds for on-demand drug and cell delivery |
EP2351779B1 (fr) * | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Microsphères et procédé de fabrication des microsphères |
KR101151688B1 (ko) * | 2010-05-18 | 2012-06-14 | 중앙대학교 산학협력단 | 색전 미세구 제조 시스템 |
US9192746B2 (en) * | 2010-06-07 | 2015-11-24 | Cook Medical Technologies Llc | Reperfusion catheter system |
GB201101429D0 (en) * | 2011-01-27 | 2011-03-16 | Biocompatibles Uk Ltd | Drug delivery system |
EP2734238B1 (fr) * | 2011-07-19 | 2020-02-19 | CellMosaic, Inc. | Réactifs de réticulation, macromolécules, conjugués thérapeutiques basés sur des alcools de sucres, et procédés de synthèse associés |
WO2013177364A1 (fr) | 2012-05-24 | 2013-11-28 | Biosphere Medical, Inc. | Biomatériaux appropriés pour être utilisés comme implants détectables par imagerie par résonance magnétique, à élution de médicament, pour une occlusion vasculaire |
CN103142491B (zh) * | 2013-02-06 | 2015-07-15 | 广东先强药业有限公司 | 一种单磷酸阿糖腺苷微球给药系统及其制备方法 |
CN103536972B (zh) * | 2013-07-05 | 2016-01-13 | 北京大学 | 磁共振成像可检测的液体栓塞组合物及其制备和应用 |
CN103536974B (zh) * | 2013-07-05 | 2015-07-15 | 北京大学 | 磁共振成像可检测的原位液晶前体栓塞组合物及其制备和应用 |
US20150080940A1 (en) * | 2013-09-13 | 2015-03-19 | Cook Medical Technologies Llc | Anti-tumor macrophage m1 morphology inducer |
WO2015042170A1 (fr) | 2013-09-17 | 2015-03-26 | Wayne State University | Compositions et utilisations de combinaisons d'indoles associés à dim et de composés anti-androgène sélectionnés |
US9546236B2 (en) | 2013-09-19 | 2017-01-17 | Terumo Corporation | Polymer particles |
WO2015042462A1 (fr) | 2013-09-19 | 2015-03-26 | Microvention, Inc. | Films polymères |
CN103550834B (zh) * | 2013-10-25 | 2015-07-15 | 北京大学 | 一种栓塞材料组合物及其制备方法和用途 |
KR102287781B1 (ko) | 2013-11-08 | 2021-08-06 | 테루모 가부시키가이샤 | 중합체 입자 |
WO2016154592A1 (fr) | 2015-03-26 | 2016-09-29 | Microvention, Inc. | Particules emboliques |
US10071181B1 (en) | 2015-04-17 | 2018-09-11 | Teleflex Innovations S.À.R.L. | Resorbable embolization spheres |
CN104865333B (zh) * | 2015-05-14 | 2016-08-24 | 武汉轻工大学 | 一种龙眼肉蛋白多糖的检测方法 |
AU2016313969B2 (en) * | 2015-06-19 | 2021-12-23 | Sillajen, Inc. | Compositions and methods for viral embolization |
GB201515602D0 (en) * | 2015-09-03 | 2015-10-21 | Biocompatibles Uk Ltd | Polymers and microspheres |
EP3347460A4 (fr) * | 2015-09-08 | 2019-04-10 | Sillajen, Inc. | Virus de la vaccine oncolytiques modifiés exprimant une cytokine et une carboxyestérase et leurs procédés d'utilisation |
US10053693B2 (en) | 2016-01-19 | 2018-08-21 | Mubin I. Syed | Method for controlling obesity using minimally invasive means |
US10182979B2 (en) | 2016-03-22 | 2019-01-22 | Regents Of The University Of Minnesota | Biodegradable microspheres |
TWI604819B (zh) * | 2016-04-13 | 2017-11-11 | Bioabsorbable bone nail capable of developing under x-ray and its making method | |
EP3442589A1 (fr) * | 2016-07-21 | 2019-02-20 | Boston Scientific Scimed Inc. | Composés injectables. |
CA3038719C (fr) | 2016-09-28 | 2020-04-21 | Terumo Corporation | Particules polymeres |
EA038657B1 (ru) * | 2016-10-12 | 2021-09-29 | Общество С Ограниченной Ответственностью "Технология Лекарств" | Химиоэмболизирующие частицы для лечения солидных опухолей |
US10869683B2 (en) | 2017-05-19 | 2020-12-22 | Boston Scientific Scimed, Inc | Systems and methods for submucosal tissue separation |
WO2018218208A1 (fr) * | 2017-05-26 | 2018-11-29 | Bruin Biosciences, Inc. | Agents pour chimio-embolisation |
WO2019082991A1 (fr) * | 2017-10-25 | 2019-05-02 | メディギア・インターナショナル株式会社 | Agent de scellement de tumeur biodégradable et biométabolique |
US11590080B2 (en) | 2017-12-18 | 2023-02-28 | C.R. Bard, Inc. | Drug-loaded biodegradable microbead compositions including drug-containing vesicular agents |
US11607388B2 (en) | 2017-12-18 | 2023-03-21 | C.R. Bard, Inc. | Drug-loaded microbead compositions, embolization compositions and associated methods |
CN109010902A (zh) * | 2018-05-04 | 2018-12-18 | 南京大学 | 一种具有抗肿瘤作用的肝素淀粉微球血管栓塞剂及制备方法 |
WO2019227398A1 (fr) * | 2018-05-31 | 2019-12-05 | Lin xi zhang | Particule d'occlusion de l'écoulement du sang, son procédé de préparation et utilisation associée |
CN108992431B (zh) * | 2018-09-30 | 2020-10-09 | 重庆医科大学附属永川医院 | 一种多柔比星栓塞微球及其制备方法 |
CN112646082B (zh) * | 2019-10-10 | 2023-06-23 | 陈忠 | 丙烯酸酯聚合物微球聚集体及其制备方法 |
CN112791228A (zh) * | 2019-11-13 | 2021-05-14 | 太阳雨林(厦门)生物医药有限公司 | 一种用于肺结核咯血的缓释栓塞微球 |
CN112972753A (zh) * | 2019-12-02 | 2021-06-18 | 太阳雨林(厦门)生物医药有限公司 | 一种用于治疗慢性炎症引起的支气管扩张性咯血的缓释栓塞微球 |
EP4213903A1 (fr) * | 2020-09-16 | 2023-07-26 | Said Farha | Système et procédé pour embolisation de vaisseau sanguin intégrée et administration de médicament localisée |
CN112305123B (zh) * | 2020-10-30 | 2021-12-28 | 河北医科大学第二医院 | 小分子物质在动脉粥样硬化性脑梗死中的应用 |
CN113975453B (zh) * | 2021-09-10 | 2023-03-07 | 苏州浩微生物医疗科技有限公司 | 水凝胶栓塞微球及其制备方法 |
CN113694248B (zh) * | 2021-09-13 | 2023-03-17 | 中山大学 | 一种基于可溶性淀粉的栓塞微球及其制备和应用 |
WO2023200921A1 (fr) * | 2022-04-13 | 2023-10-19 | Ned Medical, Inc. | Billes radio-emboliques et procédés de traitement de cellules tumorales |
Family Cites Families (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3673125A (en) * | 1969-05-10 | 1972-06-27 | Kanegafuchi Spinning Co Ltd | Method of producing polyvinyl acetal porous articles |
US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
JPS49108168A (fr) | 1973-02-16 | 1974-10-15 | ||
US4197846A (en) * | 1974-10-09 | 1980-04-15 | Louis Bucalo | Method for structure for situating in a living body agents for treating the body |
JPS5350290A (en) | 1976-10-18 | 1978-05-08 | Sumitomo Chem Co Ltd | Preparation f hydrogel |
FR2378808A1 (fr) * | 1977-01-28 | 1978-08-25 | Mar Pha Etu Expl Marques | Nouveaux copolymeres hydrophiles a base de n-(tris(hydroxy-methyl)methyl)acrylamide ou de n-(tris (hydroxymethyl)methyl)methacrylamide, leur preparation et leur emploi dans les techniques de separation |
CS204190B1 (en) * | 1978-02-22 | 1981-03-31 | Jaroslav Drobnik | Activation method for hydrxyl groups containing insoluble carriers |
DE2935712A1 (de) | 1978-09-07 | 1980-03-20 | Sumitomo Chemical Co | Verfahren zum herstellen von stark absorbierenden polymerisaten |
US4314032A (en) | 1978-10-26 | 1982-02-02 | Kureha Kagaku Kogyo Kabushiki Kaisha | Crosslinked polyvinyl alcohol gel |
US4268495A (en) * | 1979-01-08 | 1981-05-19 | Ethicon, Inc. | Injectable embolization and occlusion solution |
US4306031A (en) | 1979-08-14 | 1981-12-15 | Mitsubishi Chemical Industries Limited | Weakly acidic cation exchange resin and process for producing same |
FR2482112B1 (fr) * | 1980-05-09 | 1985-06-07 | Pharmindustrie | Nouveaux copolymeres hydrophiles a base de n-(tris (hydroxymethyl) methyl) acrylamide, procedes pour leur preparation, gels aqueux desdits copolymeres et leur utilisation comme echangeurs d'ions |
GB2088392B (en) | 1980-12-03 | 1984-05-02 | Sumitomo Chemical Co | Production of hydrogels |
JPS57128709A (en) | 1981-02-03 | 1982-08-10 | Sumitomo Chem Co Ltd | Preparation of hydrogel |
US4622362A (en) | 1981-03-30 | 1986-11-11 | California Institute Of Technology | Polyacrolein microspheres |
US4413070A (en) * | 1981-03-30 | 1983-11-01 | California Institute Of Technology | Polyacrolein microspheres |
JPS5988418A (ja) * | 1982-11-08 | 1984-05-22 | Unitika Ltd | 抗癌性物質徐放性塞栓剤 |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4500658A (en) * | 1983-06-06 | 1985-02-19 | Austenal International, Inc. | Radiopaque acrylic resin |
CA1225585A (fr) * | 1983-06-30 | 1987-08-18 | Maria T. Litvinova | Composition pour l'embolisation des vaisseaux sanguins |
GB8418772D0 (en) * | 1984-07-24 | 1984-08-30 | Geistlich Soehne Ag | Chemical substances |
FR2573436B1 (fr) | 1984-11-20 | 1989-02-17 | Pasteur Institut | Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins |
US4680171A (en) | 1985-03-15 | 1987-07-14 | William Shell | Visualization of a bloodstream circulation with biodegradable microspheres |
US5186922A (en) | 1985-03-15 | 1993-02-16 | See/Shell Biotechnology, Inc. | Use of biodegradable microspheres labeled with imaging energy constrast materials |
JP2874751B2 (ja) | 1986-04-09 | 1999-03-24 | ジェンザイム・コーポレーション | 希望する蛋白質をミルク中へ分泌する遺伝子移植動物 |
US4803075A (en) | 1986-06-25 | 1989-02-07 | Collagen Corporation | Injectable implant composition having improved intrudability |
JPS6317904A (ja) | 1986-07-09 | 1988-01-25 | Mitsubishi Chem Ind Ltd | 多孔質架橋ポリビニルアルコ−ル粒子の製造法 |
US4902505A (en) | 1986-07-30 | 1990-02-20 | Alkermes | Chimeric peptides for neuropeptide delivery through the blood-brain barrier |
US4803072A (en) * | 1986-09-10 | 1989-02-07 | Smithkline Beckman Corporation | Immunomodulation |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5116742A (en) * | 1986-12-03 | 1992-05-26 | University Patents, Inc. | RNA ribozyme restriction endoribonucleases and methods |
US4795741A (en) | 1987-05-06 | 1989-01-03 | Biomatrix, Inc. | Compositions for therapeutic percutaneous embolization and the use thereof |
US4904582A (en) | 1987-06-11 | 1990-02-27 | Synthetic Genetics | Novel amphiphilic nucleic acid conjugates |
US4873316A (en) * | 1987-06-23 | 1989-10-10 | Biogen, Inc. | Isolation of exogenous recombinant proteins from the milk of transgenic mammals |
CA1329800C (fr) * | 1987-12-29 | 1994-05-24 | Hiroaki Takayanagi | Agent composite de separation |
EP0354948A1 (fr) | 1988-02-12 | 1990-02-21 | DE ZAEPFFEL, Brigitte | Copolymere hydrophile reticule a usage medical et paramedical |
JPH064713B2 (ja) | 1988-07-22 | 1994-01-19 | テルモ株式会社 | 生体適合性材料 |
US5843156A (en) * | 1988-08-24 | 1998-12-01 | Endoluminal Therapeutics, Inc. | Local polymeric gel cellular therapy |
JPH0286838A (ja) | 1988-09-22 | 1990-03-27 | Terumo Corp | 水不溶性ヒドロゲルおよびその製造方法 |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5162430A (en) | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5550187A (en) * | 1988-11-21 | 1996-08-27 | Collagen Corporation | Method of preparing crosslinked biomaterial compositions for use in tissue augmentation |
DE3841401A1 (de) * | 1988-12-08 | 1990-06-13 | Martin Lemperle | Alloplastisches implantat |
US5258028A (en) | 1988-12-12 | 1993-11-02 | Ersek Robert A | Textured micro implants |
US5092883A (en) * | 1988-12-28 | 1992-03-03 | Eppley Barry L | Method for promoting soft connective tissue growth and repair in mammals |
JPH03503651A (ja) | 1989-01-27 | 1991-08-15 | メルク パテント ゲゼルシヤフト ミツト ベシユレンクテル ハフトング | ビフェニリルエタン化合物 |
FR2645866B1 (fr) | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
CA2017570C (fr) * | 1989-05-31 | 2000-12-19 | James R. Gross | Structure poreuse d'un polymere absorbant |
US5007940A (en) * | 1989-06-09 | 1991-04-16 | American Medical Systems, Inc. | Injectable polymeric bodies |
US5542935A (en) * | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5147937A (en) | 1990-03-22 | 1992-09-15 | Rohm And Haas Company | Process for making controlled, uniform-sized particles in the 1 to 50 micrometer range |
JP3120187B2 (ja) * | 1990-08-08 | 2000-12-25 | 武田薬品工業株式会社 | 血管新生阻害物質を含む血管内塞栓剤 |
DE69114782T2 (de) | 1990-08-08 | 1996-04-18 | Takeda Chemical Industries Ltd | Intravaskulär embolisierendes Mittel mit Gehalt an einem die Angiogenesis hemmenden Stoff. |
US5410016A (en) | 1990-10-15 | 1995-04-25 | Board Of Regents, The University Of Texas System | Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
US5117577A (en) | 1990-11-05 | 1992-06-02 | Gary Burghoff | Fish attractor device |
US5312617A (en) * | 1991-05-23 | 1994-05-17 | Unger Evan C | Liposoluble compounds useful as magnetic resonance imaging agents |
FR2676927B1 (fr) * | 1991-05-29 | 1995-06-23 | Ibf | Microspheres utilisables pour les occlusions vasculaires therapeutiques et solutions injectables les contenant. |
US5554658A (en) * | 1991-08-06 | 1996-09-10 | Rosenblatt; Solomon | Injection molded PVA Sponge |
EP0529910B1 (fr) * | 1991-08-23 | 1996-03-13 | Nippon Shokubai Co., Ltd. | Polymère réticulé hydrophile biodégradable, procédé pour sa préparation et son utilisation |
JPH082985B2 (ja) | 1991-08-26 | 1996-01-17 | 東京シート株式会社 | 高密度表層付ウレタンフォーム成形品の製造方法 |
JP3356447B2 (ja) | 1991-10-16 | 2002-12-16 | テルモ株式会社 | 乾燥高分子ゲルからなる血管病変塞栓材料 |
ATE197125T1 (de) | 1992-02-28 | 2000-11-15 | Univ Texas | Photopolymerinierbare, biologisch abbaubare hydrogele als gewebekontaktmaterialien und trägerstoffe für kontrollierte freisetzung |
JPH05294839A (ja) * | 1992-04-20 | 1993-11-09 | Biomaterial Universe Kk | シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法 |
JPH0656676A (ja) * | 1992-08-05 | 1994-03-01 | Hori Shinichi | 血管塞栓用懸濁液 |
US5514379A (en) * | 1992-08-07 | 1996-05-07 | The General Hospital Corporation | Hydrogel compositions and methods of use |
US5654006A (en) * | 1993-02-12 | 1997-08-05 | Mayo Foundation For Medical Education And Research | Condensed-phase microparticle composition and method |
US5629327A (en) * | 1993-03-01 | 1997-05-13 | Childrens Hospital Medical Center Corp. | Methods and compositions for inhibition of angiogenesis |
ES2215207T3 (es) | 1993-03-09 | 2004-10-01 | Baxter International Inc. | Microparticulas de macromoleculas y metodos de produccion. |
US5981719A (en) | 1993-03-09 | 1999-11-09 | Epic Therapeutics, Inc. | Macromolecular microparticles and methods of production and use |
EP0784487A1 (fr) * | 1993-03-19 | 1997-07-23 | Medinvent | Composition et procede d'activation tissulaire |
FR2705361B1 (fr) | 1993-05-18 | 1995-08-04 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
FR2707664B1 (fr) | 1993-07-13 | 1995-09-29 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
US5994341A (en) * | 1993-07-19 | 1999-11-30 | Angiogenesis Technologies, Inc. | Anti-angiogenic Compositions and methods for the treatment of arthritis |
US20030203976A1 (en) * | 1993-07-19 | 2003-10-30 | William L. Hunter | Anti-angiogenic compositions and methods of use |
EP1652539B8 (fr) * | 1993-07-19 | 2011-06-15 | Angiotech Pharmaceuticals, Inc. | Procédé de fabrication d'un stent comprenant une composition anti-angiogénique |
US5639872A (en) | 1993-07-27 | 1997-06-17 | Hybridon, Inc. | Human VEGF-specific oligonucleotides |
GB2281861B (en) | 1993-09-21 | 1997-08-20 | Johnson & Johnson Medical | Bioabsorbable wound implant materials containing microspheres |
DE69432867T2 (de) * | 1993-11-18 | 2004-04-22 | Sirtex Medical Ltd., Burswood | Zubereitung mit gesteuerter freisetzung |
US5698443A (en) | 1995-06-27 | 1997-12-16 | Calydon, Inc. | Tissue specific viral vectors |
US5830686A (en) | 1994-01-13 | 1998-11-03 | Calydon | Tissue-specific enhancer active in prostate |
US5583162A (en) | 1994-06-06 | 1996-12-10 | Biopore Corporation | Polymeric microbeads and method of preparation |
US5451406A (en) * | 1994-07-14 | 1995-09-19 | Advanced Uroscience, Inc. | Tissue injectable composition and method of use |
UA10911C2 (uk) * | 1994-08-10 | 1996-12-25 | Мале Впроваджувальне Підприємство "Іhтерфалл" | Біосумісhий гідрогель |
DE69520044T2 (de) | 1994-10-12 | 2001-06-13 | Focal Inc | Zielgerichte verabreichung mittels biologisch abbaubarer polymere |
US6099864A (en) * | 1994-12-02 | 2000-08-08 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | In situ activation of microcapsules |
US5955108A (en) * | 1994-12-16 | 1999-09-21 | Quadrant Healthcare (Uk) Limited | Cross-linked microparticles and their use as therapeutic vehicles |
US5716404A (en) * | 1994-12-16 | 1998-02-10 | Massachusetts Institute Of Technology | Breast tissue engineering |
DE69632392T2 (de) * | 1995-01-27 | 2004-09-16 | Scimed Life Systems, Inc., Maple Grove | Embolisationssystem |
US5855610A (en) * | 1995-05-19 | 1999-01-05 | Children's Medical Center Corporation | Engineering of strong, pliable tissues |
US6214331B1 (en) | 1995-06-06 | 2001-04-10 | C. R. Bard, Inc. | Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained |
US5888546A (en) * | 1995-08-28 | 1999-03-30 | The Regents Of The University Of California | Embolic material for endovascular occlusion of abnormal vasculature and method for using the same |
US5985177A (en) | 1995-12-14 | 1999-11-16 | Shiseido Co., Ltd. | O/W/O type multiple emulsion and method of preparing the same |
US5752974A (en) | 1995-12-18 | 1998-05-19 | Collagen Corporation | Injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
DE19601699A1 (de) * | 1996-01-18 | 1997-07-24 | Wacker Chemie Gmbh | Redispergierbare Polymerisatpulver und daraus erhältliche wäßrige Polymerisat-Dispersionen |
US5785977A (en) * | 1996-02-07 | 1998-07-28 | Breithbarth; Richard | Non-metallic microparticle carrier materials |
US5611344A (en) | 1996-03-05 | 1997-03-18 | Acusphere, Inc. | Microencapsulated fluorinated gases for use as imaging agents |
AU716443B2 (en) * | 1996-03-27 | 2000-02-24 | Biocure, Inc. | Process for manufacture of a porous polymer by use of a porogen |
US5823198A (en) * | 1996-07-31 | 1998-10-20 | Micro Therapeutics, Inc. | Method and apparatus for intravasculer embolization |
US6083484A (en) * | 1996-10-17 | 2000-07-04 | Molecular Biosystems, Inc. | Microparticles stabilized by polynuclear chromium complexes and their use as ultrasound contrast agents |
US5925683A (en) | 1996-10-17 | 1999-07-20 | Target Therapeutics, Inc. | Liquid embolic agents |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
CA2288292A1 (fr) | 1997-04-24 | 1998-10-29 | Nycomed Imaging As | Technique de traitement des emboles au moyen de microparticules ou vesicules insolubles contenant des agents de contraste |
US5861149A (en) * | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
US6048908A (en) * | 1997-06-27 | 2000-04-11 | Biopore Corporation | Hydrophilic polymeric material |
AU9313298A (en) | 1997-09-04 | 1999-03-22 | Point Biomedical Corporation | Injectable tissue reconstruction material |
AU8877098A (en) * | 1997-09-05 | 1999-03-29 | Nycomed Imaging As | Polymer particles made of polyvinyl alcohol and comprising contrast agent for chemoembolization |
US6548047B1 (en) * | 1997-09-15 | 2003-04-15 | Bristol-Myers Squibb Medical Imaging, Inc. | Thermal preactivation of gaseous precursor filled compositions |
US6565885B1 (en) * | 1997-09-29 | 2003-05-20 | Inhale Therapeutic Systems, Inc. | Methods of spray drying pharmaceutical compositions |
US6015541A (en) * | 1997-11-03 | 2000-01-18 | Micro Therapeutics, Inc. | Radioactive embolizing compositions |
GB9727518D0 (en) * | 1997-12-31 | 1998-02-25 | Nycomed Imaging As | Use |
CA2322954C (fr) * | 1998-03-06 | 2011-06-07 | Biosepra Inc. | Particules implantables faisant gonfler les tissus pour le traitement du reflux gastro-oesophagien pathologique, de l'incontinence urinaire et de des rides |
US6660301B1 (en) * | 1998-03-06 | 2003-12-09 | Biosphere Medical, Inc. | Injectable microspheres for dermal augmentation and tissue bulking |
US5891470A (en) * | 1998-04-17 | 1999-04-06 | Advanced Polymer Systems, Inc. | Softgel formulation containing retinol |
US6224794B1 (en) * | 1998-05-06 | 2001-05-01 | Angiotech Pharmaceuticals, Inc. | Methods for microsphere production |
US6165193A (en) | 1998-07-06 | 2000-12-26 | Microvention, Inc. | Vascular embolization with an expansible implant |
US6316011B1 (en) | 1998-08-04 | 2001-11-13 | Madash, Llc | End modified thermal responsive hydrogels |
US6315709B1 (en) | 1998-08-07 | 2001-11-13 | Stereotaxis, Inc. | Magnetic vascular defect treatment system |
CA2248592A1 (fr) * | 1998-08-31 | 2000-02-29 | Christopher D. Batich | Microspheres pour le traitement du cancer |
FR2784580B1 (fr) | 1998-10-16 | 2004-06-25 | Biosepra Inc | Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci |
US20040047804A1 (en) * | 1998-10-29 | 2004-03-11 | The General Hospital Corporation, A Massachusetts Corporation | Enhanced radiation therapy |
US6955661B1 (en) * | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
US6296604B1 (en) * | 1999-03-17 | 2001-10-02 | Stereotaxis, Inc. | Methods of and compositions for treating vascular defects |
US6710126B1 (en) | 1999-11-15 | 2004-03-23 | Bio Cure, Inc. | Degradable poly(vinyl alcohol) hydrogels |
KR100335866B1 (ko) * | 2000-01-06 | 2002-05-10 | 박호군 | 폴리아세트산비닐 코어/폴리비닐알코올 외피의 2중 구조를갖는 미세구형 색전재료 및 그의 제조방법 |
US6676971B2 (en) | 2000-03-13 | 2004-01-13 | Biocure, Inc. | Embolic compositions |
US6652883B2 (en) | 2000-03-13 | 2003-11-25 | Biocure, Inc. | Tissue bulking and coating compositions |
US6436424B1 (en) * | 2000-03-20 | 2002-08-20 | Biosphere Medical, Inc. | Injectable and swellable microspheres for dermal augmentation |
EP1274472A2 (fr) * | 2000-03-20 | 2003-01-15 | Biosphere Medical, Inc. | Microspheres injectables, susceptibles de foisonnement, visant a faire gonfler un tissu |
US7338657B2 (en) * | 2001-03-15 | 2008-03-04 | Biosphere Medical, Inc. | Injectable microspheres for tissue construction |
CN1430505A (zh) | 2000-03-24 | 2003-07-16 | 生物领域医疗公司 | 用于主动栓塞术的微球体 |
US20030212022A1 (en) | 2001-03-23 | 2003-11-13 | Jean-Marie Vogel | Compositions and methods for gene therapy |
FR2808026B1 (fr) | 2000-04-25 | 2002-06-14 | Alexandre Laurent | Biomateriau a base de polymere hydrophile presentant un signal specifique en imagerie par resonance magnetique et procede de preparation d'un tel biomateriau |
US6537569B2 (en) | 2001-02-14 | 2003-03-25 | Microvention, Inc. | Radiation cross-linked hydrogels |
JP4094823B2 (ja) | 2001-04-03 | 2008-06-04 | 日本碍子株式会社 | ハニカム構造体及びそのアッセンブリ |
WO2002100444A1 (fr) * | 2001-06-08 | 2002-12-19 | Biosphere Medical Inc. | Microparticules marquees a l'aide d'un metal colloidal, production et utilisation de celles-ci |
US6488952B1 (en) | 2001-08-28 | 2002-12-03 | John P. Kennedy | Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system |
US6911219B2 (en) * | 2001-09-27 | 2005-06-28 | Surgica Corporation | Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them |
CA2480579A1 (fr) | 2002-03-29 | 2003-10-16 | Marcia Buiser | Embolisation |
US7131997B2 (en) | 2002-03-29 | 2006-11-07 | Scimed Life Systems, Inc. | Tissue treatment |
US7053134B2 (en) * | 2002-04-04 | 2006-05-30 | Scimed Life Systems, Inc. | Forming a chemically cross-linked particle of a desired shape and diameter |
US7034004B2 (en) | 2002-05-07 | 2006-04-25 | University Of Florida | Peptides and methods for the control of obesity |
US7838699B2 (en) | 2002-05-08 | 2010-11-23 | Biosphere Medical | Embolization using degradable crosslinked hydrogels |
US8012454B2 (en) | 2002-08-30 | 2011-09-06 | Boston Scientific Scimed, Inc. | Embolization |
US20040156781A1 (en) * | 2002-10-15 | 2004-08-12 | Porter Christopher H. | Polymeric materials for site specific delivery to the body |
US7883490B2 (en) * | 2002-10-23 | 2011-02-08 | Boston Scientific Scimed, Inc. | Mixing and delivery of therapeutic compositions |
US7588825B2 (en) * | 2002-10-23 | 2009-09-15 | Boston Scientific Scimed, Inc. | Embolic compositions |
US20040091553A1 (en) | 2002-11-12 | 2004-05-13 | West Agro, Inc | Composition and method for mammary disinfection during winter conditions |
ES2308149T3 (es) | 2003-02-12 | 2008-12-01 | Biocompatibles Uk Limited | Composicion para la quimioemboloterapia de tumores solidos. |
US20040161466A1 (en) * | 2003-02-14 | 2004-08-19 | Biocompatibles Uk Limited | Chemoembolisation |
ES2298724T3 (es) * | 2003-02-21 | 2008-05-16 | Biocompatibles Uk Limited | Suministro de un ains a partir de agentes embolicos. |
AU2004224439B2 (en) | 2003-03-24 | 2010-07-15 | Genzyme Corporation | Temporary embolization using inverse thermosensitive polymers |
WO2005044224A2 (fr) | 2003-05-02 | 2005-05-19 | Case Western Reserve University | Systeme d'administration de medicament, faisant appel a des nanocoques polymeres |
JP4342219B2 (ja) | 2003-06-13 | 2009-10-14 | 株式会社ブリヂストン | 無機物鋳型配合組成物およびこれを用いたタイヤ用モールドの製造方法 |
AU2005212829B2 (en) * | 2004-02-16 | 2010-09-09 | Proteosys Ag | Diagnostic marker for cancer |
WO2005087193A2 (fr) | 2004-03-11 | 2005-09-22 | Biocompatibles Uk Limited | Chimioembolisation |
JP2005315107A (ja) * | 2004-04-27 | 2005-11-10 | Toyota Motor Corp | 8気筒エンジン |
WO2006013376A2 (fr) | 2004-08-04 | 2006-02-09 | Biocompatibles Uk Limited | Liberation de medicaments a partir d'agents emboliques |
WO2006027567A2 (fr) | 2004-09-07 | 2006-03-16 | Biocompatibles Uk Limited | Administration de medicaments a partir d'agents d'embolisation |
EP1804773B1 (fr) | 2004-10-25 | 2011-03-30 | CeloNova BioSciences Germany GmbH | Particules polymeres chargeables pour des applications therapeutiques et/ou diagnostiques et methode de preparation et d'utilisation de ces particules |
WO2006119968A2 (fr) | 2005-05-09 | 2006-11-16 | Biosphere Medical S.A. | Compositions et procedes d'utilisation de microspheres et agents de contraste non ioniques |
JP4180582B2 (ja) | 2005-05-16 | 2008-11-12 | 富士通株式会社 | 記憶装置 |
US7210338B2 (en) | 2005-07-29 | 2007-05-01 | Honda Motor Co., Ltd. | Valve testing device having integrated purge circuit and method of valve testing |
ATE468541T1 (de) | 2005-08-10 | 2010-06-15 | Nxp Bv | Prüfen einer integrierten schaltung, die geheiminformationen enthält |
US20090220627A1 (en) * | 2005-09-16 | 2009-09-03 | Kiyotaka Hasegawa | Novel vascular endothelial growth factor expression inhibitors |
US7626626B2 (en) | 2006-01-13 | 2009-12-01 | Micron Technology, Inc. | Method and apparatus providing pixel storage gate charge sensing for electronic stabilization in imagers |
EP1978938B1 (fr) | 2006-01-24 | 2015-09-09 | Biocompatibles UK Limited | Procédé de chargement de médicament dans des particules polymères |
US20080039890A1 (en) * | 2006-01-30 | 2008-02-14 | Surgica Corporation | Porous intravascular embolization particles and related methods |
EP1986707A2 (fr) * | 2006-01-30 | 2008-11-05 | Surgica Corporation | Particules d'embolisation intravasculaire compressible, procedes connexes et systemes d'administration |
GB0619869D0 (en) | 2006-10-07 | 2006-11-15 | Regentec Ltd | Porous particles |
JP5000969B2 (ja) | 2006-10-13 | 2012-08-15 | 株式会社リコー | カラー画像形成装置及び色ずれ補正方法 |
WO2010062678A2 (fr) | 2008-10-30 | 2010-06-03 | David Liu | Échafaudages biocompatibles poreux microsphériques, et procédés et appareil pour la fabrication de ces échafaudages |
EP2351779B1 (fr) | 2010-01-27 | 2019-04-24 | Biosphere Medical, Inc. | Microsphères et procédé de fabrication des microsphères |
US9872655B2 (en) * | 2012-03-30 | 2018-01-23 | Siemens Aktiengesellschaft | PAE treatment for BPH |
JP6056676B2 (ja) * | 2013-06-21 | 2017-01-11 | 富士通株式会社 | 電子装置及びその製造方法 |
-
2001
- 2001-03-23 CN CN01810098A patent/CN1430505A/zh active Pending
- 2001-03-23 CN CN200910204299A patent/CN101708165A/zh active Pending
- 2001-03-23 DE DE60130743T patent/DE60130743T2/de not_active Expired - Lifetime
- 2001-03-23 KR KR1020027012622A patent/KR100872884B1/ko active IP Right Grant
- 2001-03-23 EP EP07009639.1A patent/EP1820495B1/fr not_active Expired - Lifetime
- 2001-03-23 DE DE01918975T patent/DE01918975T1/de active Pending
- 2001-03-23 ES ES10179236.4T patent/ES2551164T3/es not_active Expired - Lifetime
- 2001-03-23 WO PCT/US2001/009619 patent/WO2001072281A2/fr active IP Right Grant
- 2001-03-23 AT AT01918975T patent/ATE374597T1/de not_active IP Right Cessation
- 2001-03-23 US US10/220,982 patent/US8697137B2/en active Active
- 2001-03-23 AU AU2001245988A patent/AU2001245988A1/en not_active Abandoned
- 2001-03-23 EP EP10179236.4A patent/EP2286799B1/fr not_active Expired - Lifetime
- 2001-03-23 EP EP01918975A patent/EP1267839B1/fr not_active Revoked
- 2001-03-23 JP JP2001570242A patent/JP2003528130A/ja active Pending
- 2001-03-23 KR KR1020087011444A patent/KR20080046750A/ko not_active Application Discontinuation
- 2001-03-23 ES ES01918975T patent/ES2254042T3/es not_active Expired - Lifetime
-
2008
- 2008-03-31 JP JP2008091579A patent/JP2008214355A/ja active Pending
- 2008-05-16 US US12/122,590 patent/US10265271B2/en active Active
-
2012
- 2012-02-13 US US13/371,964 patent/US8741351B2/en not_active Expired - Fee Related
- 2012-05-02 US US13/462,004 patent/US9308169B2/en not_active Expired - Lifetime
-
2013
- 2013-01-18 JP JP2013006883A patent/JP2013082743A/ja active Pending
-
2016
- 2016-03-14 JP JP2016049245A patent/JP2016147885A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001245988A1 (en) | Microspheres for active embolization | |
WO2001072280A3 (fr) | Compositions et methodes pour therapie genique | |
WO2003082188A3 (fr) | Procedes et systemes d'administration de medicaments pour le traitement de maladies bucco-faciales | |
NO20005190D0 (no) | Terapeutiske angiogene faktorer og metoder for deres anvendelse | |
EP1343492A4 (fr) | Traitement de mucosite | |
AU5056196A (en) | Hydrogel-forming, self-solvating absorbable polyester copolymers and methods for use thereof | |
WO2006002366A3 (fr) | Dispositifs oculaires biodegradables, procedes et systemes associes | |
HK1056311A1 (en) | Topical pharmaceutical formulations and methods of treatment | |
CA2235919A1 (fr) | Systeme d'administration a liberation prolongee non polymere | |
WO2005110436A3 (fr) | Implants a liberation prolongee contenant des macromolecules et leurs procedes | |
WO2005079387A3 (fr) | Systeme de liberation de medicament implantable comprenant des filaments ou des fils | |
WO2003028622A3 (fr) | Procede d'administration de medicaments a un tissu au moyen de dispositifs medicaux enrobes des medicaments | |
MXPA05007146A (es) | Copolimeros en bloque de polipeptido-poli(etilenglicol) de ramificaciones multiples como vehiculos para suministro de farmacos. | |
EP3056229A3 (fr) | Administration locale d'une combinaison de rapamycine et de 17 beta-oestradiol pour le traitement de plaques vulnérables | |
MXPA03010085A (es) | Composiciones y su uso en la hiperplasia. | |
ATE198979T1 (de) | Zielgerichte verabreichung mittels biologisch abbaubarer polymere | |
WO1998029105A3 (fr) | Methode de traitement de maladies prostatiques au moyen de formulations de vitamine d a liberation retardee et/ou prolongee | |
WO2001037896A3 (fr) | Procedes et compositions pour l'administration de reactifs therapeutiques | |
EP1982695A3 (fr) | Fabrication de dispositif d'administration de médicament à long terme avec du polyuréthane | |
WO2004034975A3 (fr) | Procede permettant de modifier le profil de liberation de compositions a liberation lente | |
EP1559431B1 (fr) | Composition pharmaceutique pour des peptides dérivés de thrombine | |
WO2004087065A3 (fr) | Composition pour l'induction d'une reponse therapeutique | |
EP1569664A4 (fr) | Poly(ortho esters) bioerodables prepares a partir de di(cetene acetals) a base de dioxane et copolymeres sequences contenant ceux-ci | |
WO2004012676A3 (fr) | Materiau biologique charge de medicament traite chimiquement par la genipine | |
WO2002060410A3 (fr) | Methodes d'administration locale a liberation prolongee de medicaments visant a l'ablation de tissus non desires |